Enzo Biochem Company Overview
About Enzo Biochem
Enzo Biochem (NYSE:ENZ) is a pioneering force in the life sciences sector, focusing on developing and commercializing proprietary technologies and products for diagnostic and research applications. The company operates through several branches, delving into areas such as molecular diagnostics, clinical lab services, and life science research reagents. Enzo aims to leverage its extensive platform to provide comprehensive and advanced solutions that meet the evolving needs of its customers within the healthcare and biotechnology communities. With a strong commitment to innovation and excellence, Enzo Biochem's projects are designed to address the complex challenges of genomic and cellular analysis, striving to enhance patient care through improved diagnostic and therapeutic tools. The company's primary objective is to solidify its position in the global life sciences industry by expanding its product offerings, advancing its technological capabilities, and fostering strategic partnerships.
Snapshot
Operations
Products and/or services of Enzo Biochem
- Clinical laboratory services offering a wide range of diagnostic tests.
- Enzyme-linked immunosorbent assays (ELISAs) for precise disease diagnosis.
- Molecular diagnostic products for infectious disease and genetic analysis.
- Therapeutic development focused on small molecule modulators.
- Life sciences research reagents for academic and commercial use.
- Custom oligonucleotides synthesis service for research applications.
Enzo Biochem executive team
- Ms. Kara CannonCEO & Director
- Ms. Patricia Eckert CPAChief Financial Officer
- Mr. Brian J. FisherGeneral Counsel & Secretary